Return to homepagePandemic Pact

Use of C-reactive protein levels in patients with COVID-19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $59,640

  • Funder

    Lundbeck Foundation

  • Principal Investigator

    Professor Henning Bliddal

  • Research Location

    Denmark

  • Lead Research Institution

    Bispebjerg Hospital

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Can a particular method of protein analysis be used to predict the risk of developing a serious case of COVID-19 - and the risk of acute respiratory distress syndrome (ARDS) - in infected individuals?